LDL increases inactive tissue factor on vascular smooth muscle cell surfaces: Hydrogen peroxide activates latent cell surface tissue factor

Circulation

Volumn 99, Issue 13, 1999, Pages 1753-1759

  Penn, Marc S ^a   Patel, Chandrashekhar V ^a   Cui, Mei Zhen ^a   DiCorleto, Paul E ^a   Chisolm, Guy M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Atherosclerosis; Coronary disease; Free radicals; Thrombosis

Indexed keywords

CELL SURFACE PROTEIN; HYDROGEN PEROXIDE; LOW DENSITY LIPOPROTEIN; THROMBOPLASTIN;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; NONHUMAN; OXIDATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0033528662     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.13.1753     Document Type: Article

References (47)

1. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA. 1989;86:2839-2843.
2. Kato K, Elsayed YA, Namoto M, Nakagawa K, Sueishi K. Enhanced expression of tissue factor activity in the atherosclerotic aortas of cholesterol-fed rabbits. Thromb Res. 1996;82:335-347.
3. Toschi V, Gallo R, Lettino M, Fallon JT, Gertz SD, Fernandex-Ortiz A, Chesebro JH, Badimon L, Nemerson Y, Fuster V, Badimon JJ. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation. 1997;95:594-599.
4. Marmur JD, Thiruvikraman SV, Fyfe BS, Guha A, Sharma SK, Ambrose JA, Fallon JT, Nemerson Y, Taubman MB. Identification of active tissue factor in human coronary atheroma. Circulation. 1996;94:1226-1232.
5. Annex BH, Denning SM, Channon KM, Sketch MH, Stack RS, Morrissey JH, Peters KG. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation. 1995;91:619-622.
6. Marmur JD, Rossikhina M, Guha A, Fyfe B, Friedrich V, Mendlowitz M, Nemerson Y, Taubman MB. Tissue factor is rapidly induced in arterial smooth muscle after balloon injury. J Clin Invest. 1993;91:2253-2259.
7. McNamara CA, Sarembock IJ, Gimple LW, Fenton JW, Coughiin SR, Owens GK. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J Clin Invest. 1993;91:94-98.
8. Chisolm GM, Penn MS. Oxidized lipoproteins and atherosclerosis. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and Coronary Artery Disease. New York, NY: Raven Press; 1996;129-149.
9. Morel DW, DiCorleto PE, Chisolm GM. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis. 1984;4:357-364.
10. Cathcart MK, Morel DW, Chisolm GM. Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic. J Leukoc Biol. 1985;38:341-350.
11. Coffey MD, Cole RA, Colles SM, Chisolm GM. In vitro cell injury by oxidized low density lipoprotein involves lipid hydroperoxide-induced formation of alkoxyl, lipid, and peroxyl radicals. J Clin Invest. 1995;96: 1866-1873.
12. Chisolm GM, Ma G, Irwin KC, Martin LL, Gunderson KG, Linberg LF, Morel DW, DiCorleto PE. 7-Hydroperoxycholest-5-en-3-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein. Proc Natl Acad Sci U S A. 1994;91: 11452-11456.
13. Katsuda S, Boyd HC, Fligner C, Ross R, Gown AM. Human atherosclerosis, III: immunocytochemical analysis of the cell composition of lesions of young adults. Am J Pathol. 1992;140:907-914.
14. Ross R, Agius L. The process of atherogenesis: cellular and molecular interaction: from experimental animal models to humans. Diabetologia. 1992;35:S34-S40.
15. 2+ mobilization and protein kinase C activation. J Clin Invest. 1993;91:547-552.
16. Surprenant YM, Zuckerman SH. A novel microtiter plate assay for the quantitation of procoagulant activity on adherent monocytes, macrophages and endothelial cells. Thromb Res. 1989;53:339-346.
17. Morel DW, Hessler JR, Chisolm GM. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J Lipid Res. 1983; 24:1070-1076.
18. Kosugi K, Morel DW, DiCorleto PE, Chisolm GM. Toxicity of oxidized low-density lipoprotein to cultured fibroblasts is selective for S phase of the cell cycle. J Cell Physiol. 1987;130:311-320.
19. Schuh J, Fairclough GF, Haschemeyer RH. Oxygen-mediated heterogeneity of apo-low-density lipoprotein. Proc Natl Acad Sci U S A. 1978;75: 3173-3177.
20. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
21. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched. Biochemistry. 1979;18:5294-5299.
22. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press; 1989.
23. Schecter AD, Giesen PLA, Taby O, Rosenfield CL, Rossikhina M, Fyte BS, Kohtz DS, Fallon JT, Nemerson Y, Taubman MB. Tissue factor expression in human arterial smooth muscle cells: tissue factor is present in three cellular pools after growth factor stimulation. J Clin Invest. 1997;100:2276-2285.
24. Nemerson Y, Pitlick FA. Purification and characterization of the protein component of tissue factor. Biochemistry. 1970;9:5100-5105.
25. Bach R, Konigsberg WH, Nemerson Y. Human tissue factor contains thioester-lined palmitate and stearate on the cytoplasmic half-cystine. Biochemistry. 1988;27:4227-4231.
26. Zioncheck TF, Toy S, Vehar GA. The cytoplasmic domain of tissue factor is phosphorylated by a protein kinase C-dependent mechanism. J Biol Chem. 1992;267:3561-3564.
27. Wijngaards G, Hemker HC. Determination of tissue thromboplastin activity. Haemostasis. 1977;6:89-97.
28. Rao GN, Berk BC. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ Res. 1992;70:593-599.
29. Roveri A, Coassin M, Maiorino M, Zamburlini A, van Amsterdam FT, Ratti E, Ursini F. Effect of hydrogen peroxide on calcium hemostasis in smooth muscle cells. Arch Biochem Biophys. 1992;297:265-270.
30. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues: implications for disorders of hemostasis and thrombosis. Am J Pathol. 1989;134:1087-1097.
31. Mulder AB, Smit JW, Bom VJJ, Blom NR, Ruiters MHJ, Halie MR, van der Meer J. Association of smooth muscle cell tissue factor with caveolae. Blood. 1996;88:1306-1313.
32. Sevinsky JR, Roa LV, Ruf W. Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway. J Cell Biol. 1996;133:293-304.
33. Le DT, Rapaport SI, Rao LVM. Relations between factor VIIa binding and expression of factor VIIa/tissue factor catalytic activity on cell surfaces. J Biol Chem. 1992;267:15447-15454.
34. Bach RR, Moldow CF. Mechanism of tissue factor activation on HL-60 cells. Blood. 1997;89:3270-3276.
35. Maynard JR, Heckman CA, Pitlick FA, Nemerson Y. Association of tissue factor activity with the surface of cultured cells. J Clin Invest. 1975;55:814-824.
36. Carson SD. Manifestation of cryptic fibroblast tissue factor occurs at detergent concentrations which dissolve the plasma membrane. Blood Coagul Fibrinol. 1996;7:303-313.
37. Greeno EW, Bach RR, Moldow CF. Apoptosis is associated with increased cell surface tissue factor procoagulant activity. Lab Invest. 1996;75:281-289.
38. Golino P, Ragni M, Cirillo P, Avvedimento VE, Feliciello A, Esposito N, Scognamiglio A, Trimarco B, Iaccarino G, Condorelli M, Chiariello M, Ambrosio G. Effects of tissue factor induced by oxygen free radicals on coronary blood flow during reperfusion. Nat Med. 1997;2:35-40.
39. Crutchley DJ, Que BG. Copper-induced tissue factor expression in human monocytic THP-1 cells and its inhibition by antioxidants. Circulation. 1995;92:238-243.
40. Kelley RF, Costas KE, O'Connell MP, Lazarus RA. Analysis of the factor Vila binding site on human tissue factor: effects of tissue factor mutations on the kinetics and thermodynamics of binding. Biochemistry. 1995;34: 10383-10392.
41. Andree HAM, Nemerson Y. Tissue factor: Regulation of activity by flow and phospholipid surface. Blood Coagul Fibrinol. 1995;6: 189-197.
42. Aupeix K, Toti F, Satta N, Bischoff P, Freyssinet JM. Oxysterols induce membrane procoagulant activity in monocytic THP-1 cells. Biochem J. 1996;314:1027-1033.
43. de Jong K, Geldwerth D, Kuypers FA. Oxidative damage does not alter membrane phospholipid asymmetry in human erythrocytes. Biochemistry. 1997;36:6768-6776.
44. Lesnik P, Vonica A, Guerin M, Moreau M, Chapman JM. Anticoagulant activity of tissue factor pathway inhibitor in human plasma is preferentially associated with dense subspecies of LDL and HDL and with Lp(a). Arterioscler Thromb. 1993;13:1066-1075.
45. Lesnik P, Dentan C, Vonica A, Moreau M, Chapman MJ. Tissue factor pathway inhibitor activity associated with LDL is inactivated by cell- and copper-mediated oxidation. Arterioscler Thromb Vasc Biol. 1995;15: 1121-1130.
46. Kamikubo Y, Nakahara Y, Takemoto S, Hamuro T, Miyamoto S, Funatsu A. Human recombinant tissue factor pathway inhibitor prevents the proliferation of cultured human neonatal aortic smooth muscle cells. FEBS Lett. 1997;407:116-120.
47. Yamabe H, Osawa H, Inuma H, Kaizuka M, Tamura NT, Sunoda S, Fujita Y, Chirato K, Onodera K. Tissue factor pathway inhibitor production by human mesangial cells in culture. Thromb Haemost. 1996;76: 215-219.